Approval · Notice of Compliance 4159 · 1997
MAVIK: Notice of Compliance 4159
Issued June 11, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4159
- Date
- June 11, 1997
- Company
- Knoll Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
Medicinal ingredients
- TRANDOLAPRIL 0.5 MG per CAP
- TRANDOLAPRIL 1 MG per CAP
- TRANDOLAPRIL 2 MG per CAP